• Tue, March 1, 2022

by: WOPRAI

Michael Turrin Maintained (ZM) at Hold with Decreased Target to $145 on, Mar 1st, 2022

by: WOPRAI

Rishi Jaluria Maintained (ZM) at Buy with Decreased Target to $200 on, Mar 1st, 2022

by: WOPRAI

Peter Levine Maintained (ZM) at Hold with Decreased Target to $145 on, Mar 1st, 2022

by: WOPRAI

Josh Beck Maintained (BIGC) at Buy with Decreased Target to $30 on, Mar 1st, 2022

by: WOPRAI

Stan Zlotsky Maintained (BIGC) at Hold with Decreased Target to $26 on, Mar 1st, 2022

by: WOPRAI

Gabriela Borges Maintained (BIGC) at Strong Buy with Decreased Target to $29 on, Mar 1st, 2022

by: WOPRAI

Scott Berg Maintained (BIGC) at Strong Buy with Decreased Target to $40 on, Mar 1st, 2022

by: WOPRAI

Parker Lane Maintained (BIGC) at Strong Buy with Decreased Target to $50 on, Mar 1st, 2022

by: WOPRAI

Timur Ivannikov Maintained (APLS) at Strong Buy with Increased Target to $114 on, Mar 1st, 2022

by: WOPRAI

Colin Sebastian Maintained (BABA) at Buy with Decreased Target to $160 on, Mar 1st, 2022

by: WOPRAI

Douglas Miehm Maintained (AUPH) at Buy with Decreased Target to $27 on, Mar 1st, 2022

by: WOPRAI

Roanna Ruiz Maintained (AVIR) at Hold with Decreased Target to $9 on, Mar 1st, 2022

by: WOPRAI

David Lebowitz Initiated (ASND) at Strong Buy and Held Target at $187 on, Mar 1st, 2022

by: WOPRAI

Joshua Pokrzywinski Maintained (CARR) at Buy with Increased Target to $55 on, Mar 1st, 2022

by: WOPRAI

Bradley Canino Maintained (ALXO) at Strong Buy with Decreased Target to $36 on, Mar 1st, 2022

by: WOPRAI

David Lebowitz Initiated (ALNY) at Strong Buy and Held Target at $223 on, Mar 1st, 2022

by: WOPRAI

Andrew Mok Upgraded (AMED) to Hold and Increased Target to $168 on, Mar 1st, 2022

by: WOPRAI

John Vinh Maintained (AMBA) at Buy with Decreased Target to $160 on, Mar 1st, 2022

by: WOPRAI

Quinn Bolton Maintained (AMBA) at Strong Buy with Decreased Target to $175 on, Mar 1st, 2022

by: WOPRAI

Kevin Cassidy Maintained (AMBA) at Strong Buy with Decreased Target to $200 on, Mar 1st, 2022

by: WOPRAI

Gary Mobley Maintained (AMBA) at Buy with Decreased Target to $175 on, Mar 1st, 2022

by: WOPRAI

Joseph Moore Maintained (AMBA) at Buy with Decreased Target to $164 on, Mar 1st, 2022

by: WOPRAI

Tore Svanberg Maintained (AMBA) at Strong Buy with Decreased Target to $190 on, Mar 1st, 2022

by: WOPRAI

Richard Shannon Maintained (AMBA) at Strong Buy with Decreased Target to $170 on, Mar 1st, 2022

by: WOPRAI

David Lebowitz Initiated (BPMC) at Hold on, Mar 1st, 2022

by: WOPRAI

John Gerdes Maintained (BP) at Strong Buy with Decreased Target to $42 on, Mar 1st, 2022

by: WOPRAI

Jason Gerberry Initiated (ACLX) at Strong Buy and Held Target at $24 on, Mar 1st, 2022

by: WOPRAI

Daina Graybosch Initiated (ACLX) at Buy and Held Target at $47 on, Mar 1st, 2022

by: WOPRAI

Whit Mayo Maintained (ACHC) at Buy with Decreased Target to $80 on, Mar 1st, 2022

by: WOPRAI

Jason Butler Maintained (ACAD) at Buy with Decreased Target to $35 on, Mar 1st, 2022

by: WOPRAI

Tazeen Ahmad Maintained (ACAD) at Hold with Decreased Target to $31 on, Mar 1st, 2022

by: WOPRAI

Andrew Baum Reiterated (ABBV) at Strong Buy with Increased Target to $170 on, Mar 1st, 2022

by: WOPRAI

Matt Miksic Initiated (ZIMV) at Sell and Held Target at $34 on, Mar 1st, 2022

by: WOPRAI

Kash Rangan Maintained (ZM) at Hold with Decreased Target to $171 on, Mar 1st, 2022

by: WOPRAI

Parker Lane Maintained (ZM) at Hold with Decreased Target to $150 on, Mar 1st, 2022

by: WOPRAI

John Abbott Maintained (ARCT) at Buy with Decreased Target to $107 on, Mar 1st, 2022

by: WOPRAI

Madhu Kumar Maintained (ARVN) at Strong Buy with Decreased Target to $110 on, Mar 1st, 2022

by: WOPRAI

Bradley Canino Maintained (ARVN) at Strong Buy with Decreased Target to $93 on, Mar 1st, 2022

by: WOPRAI

Pavel Molchanov Maintained (AMRC) at Buy with Increased Target to $70 on, Mar 1st, 2022

by: WOPRAI

Stephen Gengaro Maintained (AMRC) at Strong Buy with Decreased Target to $91 on, Mar 1st, 2022

by: WOPRAI

John Barnidge Downgraded (AMP) to Hold and Decreased Target to $325 on, Mar 1st, 2022

by: WOPRAI

Sami Badri Maintained (AMT) at Buy with Decreased Target to $300 on, Mar 1st, 2022

by: WOPRAI

Chris Pierce Initiated (ACVA) at Strong Buy and Held Target at $20 on, Mar 1st, 2022

by: WOPRAI

Elliot Wilbur Downgraded (VTRS) to Hold on, Mar 1st, 2022

by: WOPRAI

Jason Gerberry Downgraded (VTRS) to Hold and Decreased Target to $13 on, Mar 1st, 2022

by: WOPRAI

Zachary Fadem Downgraded (VRM) to Hold and Held Target at $480 on, Mar 1st, 2022

by: WOPRAI

Naved Khan Downgraded (VRM) to Hold on, Mar 1st, 2022

by: WOPRAI

John Barnidge Downgraded (VOYA) to Hold and Decreased Target to $74 on, Mar 1st, 2022

Roanna Ruiz Maintained (AVIR) at Hold with Decreased Target to $9 on, Mar 1st, 2022

Roanna Ruiz of SVB Leerink, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Hold with Decreased Target from $10 to $9 on, Mar 1st, 2022.

Roanna has made no other calls on AVIR in the last 4 months.



There is 1 other peer that has a rating on AVIR. Out of the 1 peers that are also analyzing AVIR, 0 agree with Roanna's Rating of Hold.



This is the rating of the analyst that currently disagrees with Roanna

  • Matthew Harrison of "Morgan Stanley" Downgraded from Hold to Sell and Decreased Target to $7 on, Thursday, January 6th, 2022

Like: 👍